Society of Gynecologic Oncology
Chicago, IL USA

Our News on Newswise

Women with Ovarian Cancer Gain Extra Months with Addition of Drug to Standard Chemotherapy

Coleman_2015.jpg

In a study presented March 28 at the SGO Annual Meeting on Women's Cancer, overall survival for women who received standard chemotherapy treatment plus bevacizumab was a median five months longer than for women who received the standard chemotherapy...
27-Mar-2015 9:00 AM EDT

Immunotherapy Delays Recurrence for Stage III and IV Ovarian Cancers

Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the...
27-Mar-2015 9:00 AM EDT

Medical Societies Recommend Consideration of Primary HPV Testing for Cervical Cancer Screening

Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing...
8-Jan-2015 1:00 AM EST

FDA Approval of Nonavalent HPV Vaccine Adds New Tool to Eradicate Cervical Cancer

The Food and Drug Administration’s approval of a nonavalent vaccine against the human papillomavirus (HPV) represents another important step in the eradication of cervical cancer, according to the Society of Gynecologic Oncology (SGO).
10-Dec-2014 4:30 PM EST

Primary HPV Screening Offers Important New Option for Cervical Cancer Detection, Prevention

The Society of Gynecologic Oncology (SGO) welcomes new options for detecting and preventing cervical cancer, including the primary human papillomavirus (HPV) testing recently approved by the FDA.
24-Apr-2014 2:00 PM EDT

Targeted Cancer Therapy May Treat Resistant Gynecologic Cancers

Veliparib, an oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.
21-Mar-2014 9:30 AM EDT

Women with BRCA1 Mutations May Still Be at Risk for Rare Types of Uterine Cancer After Preventive Surgery to Remove Ovaries, Fallopian Tubes

Women with BRCA1 mutations may have an increased risk for developing rare types of aggressive uterine cancer despite having their ovaries and fallopian tubes removed, suggest preliminary findings.
21-Mar-2014 10:15 AM EDT

Women with Gynecologic Cancers May Live Longer When Treated at High-Volume Medical Centers

Women with ovarian and other gynecologic cancers live significantly longer when they receive care at hospitals that treat a large number of patients with these conditions, according to research on more than 850,000 women.
21-Mar-2014 10:00 AM EDT

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.